Marchex, an AI-driven conversation analytics and customer acquisition company, will release its third quarter 2026 financial results on November 10, 2026, after market close. The company will host a conference call at 5:00 p.m. ET the same day to discuss the results and outlook. Investors can access the press release and webcast on Marchex's website. This update is important as it provides insights into Marchex's performance and future prospects in AI-powered customer engagement technology.
Marchex's upcoming third quarter 2026 financial results provide context for readers interested in technology stocks. For readers following the Technology sector, here is Pluang's market snapshot as of Oct 29, 2026 19:13 WIB: out of 150 priced US Technology stocks, only 21 rose while 127 fell. Crowdstrike Holdings Inc (CRWD) traded at USD 247.95 with a 1-day change of -7.02% and a typical hold time of 98 days, contrasting with Palo Alto Networks Inc (PANW) at USD 367.02, down 6.96% but with 91% buy orders, and Atlassian Corporation PLC (TEAM) at USD 205.75, down 6.53% yet showing 100% buy order activity.
The inaugural SportsTech Breakthrough Awards recognized leading companies and technologies advancing sports technology globally. Winners span categories like athlete performance, wearables, AI analytics, fan engagement, and smart stadium solutions, h...
The global Industrial Control System (ICS) Security Market is projected to grow from $17.91 billion in 2026 to $38.48 billion by 2031, at a CAGR of 16.5%. This growth is driven by rising cyberattacks targeting critical infrastructure and the increasi...
AdvantageLumber.com has introduced Sketch-A-Deck, a free online software that simplifies deck design for homeowners and contractors. The tool allows users to draw custom deck layouts, attach them to their homes, and generate build-ready plans with de...
Immunocore Holdings will present Phase 1/2 clinical trial data for brenetafusp alone and combined with KIMMTRAK in treating metastatic uveal melanoma at the 2026 Society for Immunotherapy of Cancer meeting. This trial evaluates safety and efficacy in...
Naples Comprehensive Health (NCH) has completed the first tricuspid valve repair in the US using the PASCAL Precision system following FDA approval. This minimally invasive catheter-based procedure offers a new treatment option for patients with seve...
